Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Oaktree Acquisition III Life Sciences EBIT Margin 2025-2024 | OACC

Current and historical EBIT (Earnings Before Interest & Taxes) margin for Oaktree Acquisition III Life Sciences (OACC) over the last 10 years. The current EBIT profit margin for Oaktree Acquisition III Life Sciences as of September 30, 2024 is .
  
Oaktree Acquisition III Life Sciences EBIT Margin Historical Data
Date TTM Revenue TTM EBIT EBIT Margin
Sector Industry Market Cap Revenue
$0.224B $0.000B
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
Stock Name Country Market Cap PE Ratio
PicoCELA (PCLA) Japan $0.173B 0.00
Aduro Clean Technologies (ADUR) Canada $0.156B 0.00
Range Capital Acquisition (RANG) United States $0.140B 0.00
Tavia Acquisition (TAVI) $0.139B 0.00
CO2 Energy Transition (NOEM) $0.095B 0.00
Leishen Energy Holding (LSE) China $0.089B 0.00
YHN Acquisition I (YHNA) $0.081B 0.00
Youxin Technology (YAAS) $0.065B 0.00
YSX Tech (YSXT) China $0.062B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.026B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.019B 0.00
Sky Quarry (SKYQ) $0.016B 0.00
Flowco Holdings (FLOC) $0.000B 0.00